ES2195573T3 - Preparado farmaceutico solido con estructura multifase para administracion oral de gatifloxacina o sus sales o hidratos farmaceuticamente utilizables y procedimiento para su preparacion. - Google Patents
Preparado farmaceutico solido con estructura multifase para administracion oral de gatifloxacina o sus sales o hidratos farmaceuticamente utilizables y procedimiento para su preparacion.Info
- Publication number
- ES2195573T3 ES2195573T3 ES99923491T ES99923491T ES2195573T3 ES 2195573 T3 ES2195573 T3 ES 2195573T3 ES 99923491 T ES99923491 T ES 99923491T ES 99923491 T ES99923491 T ES 99923491T ES 2195573 T3 ES2195573 T3 ES 2195573T3
- Authority
- ES
- Spain
- Prior art keywords
- salts
- preparation
- oral administration
- solid pharmaceutical
- binders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Preparado farmacéutico sólido con estructura de varias fases para administración oral, que contiene gatifloxacina o sales o hidratos de ésta farmacéuticamente utilizables y sustancias auxiliares del grupo formado por sustancias de relleno, aglutinantes, lubricantes, aceleradores de desintegración o mezclas de ellos, caracterizado porque la fase interior contiene el principio activo gatifloxacina o sales o hidratos de ésta farmacéuticamente utilizables, junto con sustancias auxiliares del grupo formado por aglutinantes, sustancias de relleno, aglutinantes, aceleradores de desintegración o mezclas de ellos, y como mínimo una fase exterior que consiste en forzosamente como mínimo un acelerador de desintegración y otras sustancias auxiliares del grupo formado por como mínimo un lubricante, en caso dado sustancias de relleno y/o en caso dado aglutinantes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19820801A DE19820801A1 (de) | 1998-05-09 | 1998-05-09 | Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2195573T3 true ES2195573T3 (es) | 2003-12-01 |
Family
ID=7867223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99923491T Expired - Lifetime ES2195573T3 (es) | 1998-05-09 | 1999-04-29 | Preparado farmaceutico solido con estructura multifase para administracion oral de gatifloxacina o sus sales o hidratos farmaceuticamente utilizables y procedimiento para su preparacion. |
Country Status (28)
Country | Link |
---|---|
US (1) | US6291462B1 (es) |
EP (1) | EP1077703B1 (es) |
JP (1) | JP2002514600A (es) |
KR (1) | KR100587210B1 (es) |
CN (1) | CN1198615C (es) |
AR (1) | AR019279A1 (es) |
AT (1) | ATE235242T1 (es) |
AU (1) | AU753482B2 (es) |
BR (1) | BR9910350A (es) |
CA (1) | CA2325636A1 (es) |
CO (1) | CO5050341A1 (es) |
DE (2) | DE19820801A1 (es) |
DK (1) | DK1077703T3 (es) |
ES (1) | ES2195573T3 (es) |
HK (1) | HK1033281A1 (es) |
HU (1) | HUP0101597A3 (es) |
IL (1) | IL139512A0 (es) |
MY (1) | MY118569A (es) |
NO (1) | NO20005385L (es) |
NZ (1) | NZ507968A (es) |
PE (1) | PE20000480A1 (es) |
PL (1) | PL343936A1 (es) |
PT (1) | PT1077703E (es) |
RU (1) | RU2226394C2 (es) |
SK (1) | SK16772000A3 (es) |
UA (1) | UA60364C2 (es) |
WO (1) | WO1999058129A1 (es) |
ZA (1) | ZA200006440B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU773218B2 (en) * | 1999-10-08 | 2004-05-20 | Debiopharm International Sa | Fab I inhibitors |
US6413969B1 (en) * | 2000-09-13 | 2002-07-02 | Bristol-Myers Squibb Company | Gatifloxacin pentahydrate |
DE60230934D1 (de) * | 2001-04-06 | 2009-03-05 | Affinium Pharm Inc | Fab-i-inhibitoren |
US6589955B2 (en) * | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
JP4859460B2 (ja) * | 2002-12-06 | 2012-01-25 | アフィニウム ファーマシューティカルズ, インク. | ヘテロ環化合物、その製造方法および治療におけるその使用 |
CA2519429C (en) | 2003-03-17 | 2013-08-06 | Affinium Pharmaceuticals, Inc. | Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
US20050031683A1 (en) * | 2003-08-04 | 2005-02-10 | Ashish Kapoor | Solid pharmaceutical composition |
WO2005021000A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Solid oral dosage forms of gatifloxacin |
AR048431A1 (es) * | 2004-03-17 | 2006-04-26 | Novartis Ag | Formulaciones galenicas de compuestos organicos |
WO2007053131A2 (en) | 2004-06-04 | 2007-05-10 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as antibiotic agents |
US20060247255A1 (en) * | 2005-05-02 | 2006-11-02 | Patel Satishkumar A | Method for preparing a stable gatifloxacin composition |
EP1909736B1 (en) * | 2005-08-02 | 2014-11-12 | Baxter International Inc. | Oxygen indicator for use in medical products and packet containing oxygen indicator |
CA2632476A1 (en) * | 2005-12-05 | 2007-06-14 | Affinium Pharmaceuticals, Inc. | Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
CA2658506C (en) | 2006-07-20 | 2016-01-26 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab 1 inhibitors |
CN100415212C (zh) * | 2006-07-21 | 2008-09-03 | 哈药集团制药总厂 | 一种含乳酸卡德沙星的口服制剂 |
CA2563690C (en) * | 2006-10-12 | 2014-10-07 | Pharmascience Inc. | Pharmaceutical compositions comprising intra- and extra- granular fractions |
WO2008098374A1 (en) * | 2007-02-16 | 2008-08-21 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab i inhibitors |
WO2013190384A1 (en) | 2012-06-19 | 2013-12-27 | Affinium Pharmaceuticals, Inc. | Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
MX2018010254A (es) | 2016-02-26 | 2018-12-19 | Debiopharm Int Sa | Medicamento para el tratamiento de infecciones de pie diabetico. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH089597B2 (ja) | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
AU653203B2 (en) * | 1991-01-30 | 1994-09-22 | Wellcome Foundation Limited, The | Water-dispersible tablets |
GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
US5436253A (en) * | 1993-09-08 | 1995-07-25 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivatives and mycotic infections |
ES2210321T3 (es) * | 1994-12-19 | 2004-07-01 | Daiichi Pharmaceutical Co., Ltd. | Preparacion granular de liberacion prolongada y procedimiento de produccion. |
US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
-
1998
- 1998-05-09 DE DE19820801A patent/DE19820801A1/de not_active Withdrawn
-
1999
- 1999-04-22 MY MYPI99001588A patent/MY118569A/en unknown
- 1999-04-29 DK DK99923491T patent/DK1077703T3/da active
- 1999-04-29 IL IL13951299A patent/IL139512A0/xx unknown
- 1999-04-29 AU AU40352/99A patent/AU753482B2/en not_active Ceased
- 1999-04-29 RU RU2000130202/15A patent/RU2226394C2/ru not_active IP Right Cessation
- 1999-04-29 HU HU0101597A patent/HUP0101597A3/hu unknown
- 1999-04-29 PT PT99923491T patent/PT1077703E/pt unknown
- 1999-04-29 UA UA2000126915A patent/UA60364C2/uk unknown
- 1999-04-29 CA CA002325636A patent/CA2325636A1/en not_active Abandoned
- 1999-04-29 NZ NZ507968A patent/NZ507968A/xx unknown
- 1999-04-29 EP EP99923491A patent/EP1077703B1/de not_active Expired - Lifetime
- 1999-04-29 AT AT99923491T patent/ATE235242T1/de not_active IP Right Cessation
- 1999-04-29 JP JP2000547980A patent/JP2002514600A/ja active Pending
- 1999-04-29 BR BR9910350-8A patent/BR9910350A/pt not_active IP Right Cessation
- 1999-04-29 KR KR1020007012442A patent/KR100587210B1/ko not_active IP Right Cessation
- 1999-04-29 SK SK1677-2000A patent/SK16772000A3/sk unknown
- 1999-04-29 WO PCT/EP1999/002893 patent/WO1999058129A1/de active IP Right Grant
- 1999-04-29 US US09/700,055 patent/US6291462B1/en not_active Expired - Fee Related
- 1999-04-29 DE DE59904737T patent/DE59904737D1/de not_active Expired - Fee Related
- 1999-04-29 PL PL99343936A patent/PL343936A1/xx unknown
- 1999-04-29 CN CNB998059897A patent/CN1198615C/zh not_active Expired - Fee Related
- 1999-04-29 ES ES99923491T patent/ES2195573T3/es not_active Expired - Lifetime
- 1999-05-03 PE PE1999000361A patent/PE20000480A1/es not_active Application Discontinuation
- 1999-05-04 CO CO99027132A patent/CO5050341A1/es unknown
- 1999-05-07 AR ARP990102177A patent/AR019279A1/es active IP Right Grant
-
2000
- 2000-10-26 NO NO20005385A patent/NO20005385L/no not_active Application Discontinuation
- 2000-11-08 ZA ZA200006440A patent/ZA200006440B/en unknown
-
2001
- 2001-06-14 HK HK01104097A patent/HK1033281A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20005385D0 (no) | 2000-10-26 |
CO5050341A1 (es) | 2001-06-27 |
KR20010043408A (ko) | 2001-05-25 |
EP1077703B1 (de) | 2003-03-26 |
IL139512A0 (en) | 2001-11-25 |
PT1077703E (pt) | 2003-08-29 |
NO20005385L (no) | 2000-10-26 |
AU4035299A (en) | 1999-11-29 |
CN1198615C (zh) | 2005-04-27 |
DE59904737D1 (de) | 2003-04-30 |
US6291462B1 (en) | 2001-09-18 |
DE19820801A1 (de) | 1999-11-25 |
JP2002514600A (ja) | 2002-05-21 |
HK1033281A1 (en) | 2001-08-24 |
PL343936A1 (en) | 2001-09-10 |
AR019279A1 (es) | 2002-02-13 |
UA60364C2 (uk) | 2003-10-15 |
DK1077703T3 (da) | 2003-06-23 |
AU753482B2 (en) | 2002-10-17 |
NZ507968A (en) | 2002-12-20 |
EP1077703A1 (de) | 2001-02-28 |
KR100587210B1 (ko) | 2006-06-08 |
RU2226394C2 (ru) | 2004-04-10 |
SK16772000A3 (sk) | 2001-05-10 |
CA2325636A1 (en) | 1999-11-18 |
HUP0101597A3 (en) | 2003-01-28 |
HUP0101597A2 (hu) | 2001-11-28 |
CN1300216A (zh) | 2001-06-20 |
ATE235242T1 (de) | 2003-04-15 |
WO1999058129A1 (de) | 1999-11-18 |
BR9910350A (pt) | 2001-09-25 |
PE20000480A1 (es) | 2000-05-20 |
ZA200006440B (en) | 2002-02-08 |
MY118569A (en) | 2004-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2195573T3 (es) | Preparado farmaceutico solido con estructura multifase para administracion oral de gatifloxacina o sus sales o hidratos farmaceuticamente utilizables y procedimiento para su preparacion. | |
AR035500A1 (es) | Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina. | |
ECSP003847A (es) | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco | |
ES2126536B1 (es) | "preparado farmaceutico para administracion intranasal y procedimientopara su produccion". | |
IL138767A0 (en) | Anticancer compositions | |
BRPI0709847B8 (pt) | composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio | |
BR0016496A (pt) | Sistema de armazenamento para medicamentos em forma de pó e inalador equipado para isso | |
CY1111153T1 (el) | Μορφη οσμοτικης δοσολογιας παρατεταμενης απελευθερωσης | |
CL2010000816A1 (es) | Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06) | |
BRPI0508125A (pt) | formulação de alcalóide, método para melhorar a eficácia de um alcalóide, uso do produto da reação de um ou mais alcalóides com um mais derivados de fosfato de um ou mais agentes de transferência de elétrons, junto com excipientes e composição farmacêutica | |
ECSP034868A (es) | Cápsulas para inhalación | |
MXPA06011467A (es) | Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid). | |
AR025052A1 (es) | Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos. | |
ECSP066553A (es) | Formas de administración masticables, no comprimidas dosificadas individualmente. | |
CO5011053A1 (es) | Procedimiento para la produccion de una forma de dosificacion solida que contiene carvedilol e hidroclorotiazida y formas farmaceuticas obtenidas por dicho procedimiento | |
ATE287264T1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
PA8548301A1 (es) | Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion | |
AR030662A1 (es) | Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos | |
TW200507838A (en) | Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator | |
AR043016A2 (es) | Un compuesto antimigranico eletriptan y composicion farmaceutica que lo contiene | |
AR042308A1 (es) | Medicamento de administracion transdermica y transmucosica con absorcion mejorada de principios activos | |
SV2006002224A (es) | Composicion farmaceutica ref. bhco41368-sv | |
MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
TW200621224A (en) | Pharmaceutical composition | |
PT1233786E (pt) | Produto contendo pelo menos uma substancia inibidora das no sintases associada a pelo menos uma substancia inibidora das fosfolipases a2 para preparacao de um medicamento |